Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism GPR3 antagonists(G protein-coupled receptor 3 antagonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H20ClN5O |
InChIKeyWBYNZQXAAWPAGR-UHFFFAOYSA-N |
CAS Registry1637300-25-4 |